Menlo Park, United States
Longitude Capital specializes in making venture growth investments in biotechnology, medical technology and health solutions companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system costs. Longitude Capital invests in both privately held and publicly traded life science companies through a variety of investment approaches. Media Contact: Maggie Jamison [email protected]
83
Total Investments
62
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Biotechnology, Finance +1
Funding Stage
Pre Seed +4
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Longitude Capital
Recent Investments (83)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Jan 2025 | |
| Series D | •••••• | Nov 2024 | |
| Series C | •••••• | Jun 2024 | |
| Series C | •••••• | May 2024 | |
| Series C | •••••• | Apr 2024 | |
•••• ••••
|
Series D | •••••• | Feb 2024 |
|
•••• ••••
|
Series C | •••••• | Feb 2024 |
|
•••• ••••
|
Series E | •••••• | Jan 2024 |
|
•••• ••••
|
Series B | •••••• | Dec 2023 |
|
•••• ••••
|
Series A | •••••• | Nov 2023 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
